What's the Matter with Distal Deep Vein Thrombosis?

Stefano Barco

doi:10.1055/s-0039-1696983

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2019; 119(10): 1547-1549
DOI: 10.1055/s-0039-1696983

Invited Editorial Focus

Georg Thieme Verlag KG Stuttgart · New York

What's the Matter with Distal Deep Vein Thrombosis?

Stefano Barco

¹Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany

References
1 Palareti G, Agnelli G, Imberti D. , et al; MASTER investigators. A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry. Thromb Haemost 2008; 99 (01) 241-244
2 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149 (02) 315-352
3 Kalayci A, Gibson CM, Chi G. , et al. Asymptomatic deep vein thrombosis is associated with an increased risk of death: insights from the APEX trial. Thromb Haemost 2018; 118 (12) 2046-2052
4 Albertsen IE, Nielsen PB. Searching for high-risk venous thromboembolism patients using risk scores: adding to the heap or closing a gap?. Thromb Haemost 2018; 118 (10) 1686-1687
5 Roetker NS, Lutsey PL, Zakai NA, Alonso A, Adam TJ, MacLehose RF. All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism. Thromb Haemost 2018; 118 (09) 1637-1645
6 Khorana AA, Weitz JI. Treatment challenges in venous thromboembolism: an appraisal of rivaroxaban studies. Thromb Haemost 2018; 118 (S 01): S23-S33
7 Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: past, present and future. Thromb Haemost 2017; 117 (07) 1219-1229
8 Cohen AT, Gitt AK, Bauersachs R. , et al. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry. Thromb Haemost 2017; 117 (07) 1326-1337
9 Blondon M, Spirk D, Kucher N. , et al. Comparative performance of clinical risk assessment models for hospital-acquired venous thromboembolism in medical patients. Thromb Haemost 2018; 118 (01) 82-89
10 Ageno W, Mantovani LG, Haas S. , et al. Patient management strategies and long-term outcomes in isolated distal deep-vein thrombosis versus proximal deep-vein thrombosis: findings from XALIA. TH Open 2019; 3 (01) e85-e93
11 Spirk D, Husmann M, Willenberg T. , et al. Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry. Thromb Haemost 2011; 105 (02) 239-244
12 Schellong S, Goldhaber S, Weitz J. , et al. Isolated distal deep vein thrombosis: perspectives from the GARFIELD-VTE Registry. Thromb Haemost 2019; 119 (09) 1675-1685
13 Weitz JI, Haas S, Ageno W. , et al. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design. Thromb Haemost 2016; 116 (06) 1172-1179
14 Trinchero A, Scheres LJJ, Prochaska JH. , et al. Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis. Thromb Res 2018; 172: 74-79
15 Galanaud JP, Sevestre-Pietri MA, Bosson JL. , et al; OPTIMEV-SFMV Investigators. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 2009; 102 (03) 493-500
16 Righini M, Paris S, Le Gal G, Laroche JP, Perrier A, Bounameaux H. Clinical relevance of distal deep vein thrombosis. Review of literature data. Thromb Haemost 2006; 95 (01) 56-64
17 Mumoli N, Vitale J, Giorgi-Pierfranceschi M. , et al; PRACTICUS Study Investigators. General practitioner-performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: a multicenter, prospective cohort study. Ann Fam Med 2017; 15 (06) 535-539
18 Shahi F, Murali K. Variations in ultrasound scanning protocols in the UK for suspected deep vein thrombosis in outpatients. Phlebology 2013; 28 (08) 397-403
19 Ageno W, Haas S, Weitz JI. , et al; GARFIELD-VTE investigators. Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE Registry. Thromb Haemost 2019; 119 (02) 319-327
20 Sartori M, Cosmi B, Legnani C. , et al. The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis. J Thromb Haemost 2012; 10 (11) 2264-2269
21 Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 2016; 115 (02) 399-405
22 Righini M, Le Gal G, Bounameaux H. Venous thromboembolism diagnosis: unresolved issues. Thromb Haemost 2015; 113 (06) 1184-1192
23 Barco S, Klok FA, Mahé I. , et al; RIETE Investigators. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 2019; 173: 166-171
24 Galanaud JP, Arnoult AC, Sevestre MA. , et al; OPTIMEV-SFMV Investigators. Impact of anatomical location of lower limb venous thrombus on the risk of subsequent cancer. Thromb Haemost 2014; 112 (06) 1129-1136
25 Barco S, Corti M, Trinchero A. , et al. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost 2017; 15 (07) 1436-1442
26 Kyrle PA, Kammer M, Eischer L. , et al. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J Thromb Haemost 2016; 14 (12) 2402-2409
27 Galanaud JP, Sevestre MA, Genty C. , et al; OPTIMEV-SFMV investigators. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 2014; 12 (04) 436-443
28 Brateanu A, Patel K, Chagin K. , et al. Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis. Thromb Haemost 2016; 115 (03) 608-614
29 Valerio L, Ambaglio C, Barone M. , et al. Recurrence risk after first symptomatic distal versus proximal deep vein thrombosis according to baseline risk factors. TH Open 2019; 3 (01) e58-e63
30 Galanaud JP, Sevestre MA, Pernod G. , et al. Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study. J Thromb Haemost 2017; 15 (05) 907-916
31 Dentali F, Pegoraro S, Barco S. , et al. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study. J Thromb Haemost 2017; 15 (09) 1757-1763
32 Palareti G, Cosmi B, Lessiani G. , et al. Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 2010; 104 (05) 1063-1070
33 Righini M, Galanaud JP, Guenneguez H. , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Lancet Haematol 2016; 3 (12) e556-e562